Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample

被引:3
|
作者
Radestig, Maya Arvidsson [1 ,2 ]
Skoog, Ingmar [1 ,2 ,3 ]
Skillback, Tobias [1 ,2 ]
Zetterberg, Henrik [2 ,4 ,5 ,6 ,7 ]
Kern, Jurgen [1 ]
Zettergren, Anna [1 ,2 ]
Andreasson, Ulf [2 ,4 ]
Wetterberg, Hanna [1 ,2 ]
Kern, Silke [1 ,2 ,3 ]
Blennow, Kaj [2 ,4 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neuropsychiat,Epidemiol Unit, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Psychiat Cognit & Old Age Psychiat, Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden
[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England
[6] UK Dementia Res Inst UCL, London WC1N 3BG, England
[7] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
基金
欧盟地平线“2020”; 美国国家卫生研究院; 欧洲研究理事会;
关键词
Alzheimer's disease; Cerebrospinal fluid; CSF; biomarkers; Neurolfilament light; NfL; Neurogranin; ALZHEIMERS-DISEASE; NEUROFILAMENT LIGHT; TAU; NEUROGRANIN; DEMENTIA; PROTEIN; BRAIN; A-BETA(1-42); ASSOCIATION; MARKER;
D O I
10.1186/s13195-023-01193-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNeurofilament light (NfL) and neurogranin (Ng) are promising candidate AD biomarkers, reflecting axonal and synaptic damage, respectively. Since there is a need to understand the synaptic and axonal damage in preclinical Alzheimer's disease (AD), we aimed to determine the cerebrospinal fluid (CSF) levels of NfL and Ng in cognitively unimpaired elderly from the Gothenburg H70 Birth Cohort Studies classified according to the amyloid/tau/neurodegeneration (A/T/N) system.MethodsThe sample consisted of 258 cognitively unimpaired older adults (age 70, 129 women and 129 men) from the Gothenburg Birth Cohort Studies. We compared CSF NfL and Ng concentrations in A/T/N groups using Student's T-test and ANCOVA.ResultsCSF NfL concentration was higher in the A-T-N+ group (p=0.001) and the A-T+N+ group (p=0.006) compared with A-T-N-. CSF Ng concentration was higher in the A-T-N+, A-T+N+, A+T-N+, and A+T+N+ groups (p<0.0001) compared with A-T-N-. We found no difference in NfL or Ng concentration in A+ compared with A- (disregarding T- and N- status), whereas those with N+ had higher concentrations of NfL and Ng compared with N- (p<0.0001) (disregarding A- and T- status).ConclusionsCSF NfL and Ng concentrations are increased in cognitively normal older adults with biomarker evidence of tau pathology and neurodegeneration.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer's Disease Continuum
    Wang, Jun
    Zhang, Xin
    Zhu, Bihong
    Fu, Pan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 183 - 190
  • [22] Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
    Tobieson, Lovisa
    Zetterberg, Henrik
    Blennow, Kaj
    Marklund, Niklas
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [23] No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients
    Becker, Madlyne
    Latarche, Clotilde
    Roman, Emilie
    Debouverie, Marc
    Malaplate-Armand, Catherine
    Guillemin, Francis
    BMC NEUROLOGY, 2015, 15
  • [24] Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
    Shreyasee Das
    Julie Goossens
    Dirk Jacobs
    Nele Dewit
    Yolande A. L. Pijnenburg
    Sjors G. J. G. In ‘t Veld
    Charlotte E. Teunissen
    Eugeen Vanmechelen
    Alzheimer's Research & Therapy, 15
  • [25] Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives
    Oeckl, Patrick
    Steinacker, Petra
    Feneberg, Emily
    Otto, Markus
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2015, 1854 (07): : 757 - 768
  • [26] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
    Johansson, Per
    Mattsson, Niklas
    Hansson, Oskar
    Wallin, Anders
    Johansson, Jan-Ove
    Andreasson, Ulf
    Zetterberg, Henrik
    Blennow, Kaj
    Svensson, Johan
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 (03) : 537 - 546
  • [27] Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease
    Chatterjee, Madhurima
    Del Campo, Marta
    Morrema, Tjado H. J.
    de Waal, Matthijs
    van der Flier, Wiesje M.
    Hoozemans, Jeroen J. M.
    Teunissen, Charlotte E.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [28] Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia
    Alvarez, Ignacio
    Aguilar, Miquel
    Manuel Gonzalez, Jose
    Ysamat, Montse
    Lorenzo-Bosquet, Carles
    Alonso, Alvaro
    Pablo Tartari, Juan
    Romero, Silvia
    Diez-Fairen, Monica
    Carcel, Maria
    Pujalte, Francisco
    Pastor, Pau
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (01) : 135 - 143
  • [29] Neuropathologic Correlates of Cognition in a Population-Based Sample
    Cholerton, Brenna
    Larson, Eric B.
    Baker, Laura D.
    Craft, Suzanne
    Crane, Paul K.
    Millard, Steven P.
    Sonnen, Joshua A.
    Montine, Thomas J.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 36 (04) : 699 - 709
  • [30] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis with the C9ORF72 Repeat Expansion
    Kamalainen, Anna
    Herukka, Sanna-Kaisa
    Hartikainen, Paivi
    Helisalmi, Seppo
    Moilanen, Virpi
    Knuuttila, Anna
    Jansson, Lilja
    Tienari, Pentti J.
    Remes, Anne M.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2015, 39 (5-6) : 287 - 293